Latest News and Press Releases
Want to stay updated on the latest news?
-
Did you buy SRAD Class A ordinary shares between November 7, 2024, and April 21, 2026? Affected SRAD Investor Summary Who: Sportradar Group AG (NASDAQ: SRAD)What: Securities fraud class action...
-
LOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Lucid Group, Inc., (“Lucid” or the "Company") (NASDAQ: LCID) investors of a class action on behalf of investors that...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Alphatec (ATEC) To Contact Him Directly To Discuss Their Options If you purchased or...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zoetis (ZTS) To Contact Him Directly To Discuss Their Options If you purchased or...
-
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. ...
-
Simulation Plus, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws
-
Beta Bionics, Inc. Securities Fraud Investigation – Robbins LLP is Investigating Investor Losses in BBNX Due to Possible Violations of Securities Laws
-
ATLANTA, June 03, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Grace Therapeutics, Inc. (“Grace Therapeutics” or the “Company”) (NASDAQ: GRCE) complied with federal...
-
Robbins Geller is investigating whether PicS N.V. and certain of its top executives made materially false and/or misleading statements to investors.
-
The case alleges that Zoetis and certain of its top executive made false and/or misleading statements to investors.